STAND. COM. REP. NO.  948-20


Honolulu, Hawaii

                , 2020


RE:   H.B. No. 2097

      H.D. 2





Honorable Scott K. Saiki

Speaker, House of Representatives

Thirtieth State Legislature

Regular Session of 2020

State of Hawaii




     Your Committee on Finance, to which was referred H.B. No. 2097, H.D. 2, entitled:




begs leave to report as follows:


     The purpose of this measure is to amend the medical cannabis dispensary system law by:


     (1)  Allowing for a process to remediate and retest any batch of cannabis or manufactured cannabis products that fails laboratory testing standards so long as any final product passes the laboratory standards;


     (2)  Authorizing licensed dispensaries to manufacture and distribute edible cannabis products under certain conditions; and


     (3)  Authorizing licensed dispensaries to circulate, sponsor, and promote educational and scientific information and events related to cannabis that shall not be considered advertising, under certain conditions.


     Your Committee received testimony in support of this measure from the Community Alliance on Prisons, Hawaii Cannabis Industry Association, Maui Grown Therapies, KUSH Bottles Hawaii, and three individuals.  Your Committee received testimony in opposition of this measure from the Department of Transportation, Department of the Prosecuting Attorney of the City and County of Honolulu, Honolulu Police Department, and one individual.  Your Committee received comments on this measure from the Department of Health.   


     As affirmed by the record of votes of the members of your Committee on Finance that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2097, H.D. 2, and recommends that it pass Third Reading.


Respectfully submitted on behalf of the members of the Committee on Finance,